Researchers develop promising recombinant flu vaccine using nanoliposome technology

WCG Clinical reports that failure rates for clinical trials involving the central nervous system (CNS) exceed 85% during Phases II and III. Reasons for this

Roche announced the agreement at its annual pharma day in London, UK. Image shows Roche’s head office in California, USA. Credit: Michael Vi via Shutterstock.

Should “site neutrality” — the idea of paying the same rate for the same service no matter where it is provided — be applied when